Company / Operating Cash Flow per Share
Tyra Biosciences, Inc. Operating Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.22
FY2024
5-year range
-$5.03 / -$1.17
FY2020-FY2024
Trend
-3.9%
vs FY2023
Sector context
#120 of 212
Health Care
What the data says
At $-1.22, Tyra Biosciences, Inc.'s operating cash flow per share ranks #120 of 212 in the Health Care sector.
Based on SEC 10-K filings.
-1.22 in FY2024.
Remained stable around $-1.22 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 212 in Health CareTop 57% of 212This company -$1.22 Sector average -$14.72
▼
+91.7% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 3.9% year-over-year.
- Ranks #120 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.22 | -3.9% |
| FY2023 | -$1.17 | +2.2% |
| FY2022 | -$1.20 | +30.3% |
| FY2021 | -$1.72 | +65.8% |
| FY2020 | -$5.03 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026